Stay updated on Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Napoli, Italy, 80131 was updated to Naples, Italy, 80131 in the locations listing, a Genetic and Rare Diseases Information Center resource was added, the Hepatocellular carcinoma term was added, and the revision version changed from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T17:19:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. The change does not modify visible study details, eligibility criteria, locations, or outcomes on the page.
    Difference
    0.0%
    Check dated 2026-03-07T05:20:55.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T13:33:53.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, a minor system update with no user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:16:53.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Glossary visibility controls were added (Show glossary / Hide glossary) and the page revision updated to v3.4.0. Update-related fields were reorganized: Last Update Submitted that Met QC Criteria and Last Update Posted were added, while the previous labels Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), and No FEAR Act Data were removed or adjusted.
    Difference
    0.1%
    Check dated 2026-01-22T17:34:50.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. This appears to be a metadata/version update and does not alter study details, eligibility criteria, or locations.
    Difference
    0.0%
    Check dated 2026-01-15T10:23:41.000Z thumbnail image

Stay in the know with updates to Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page.